Panel & Audience Discussion: Exploring the Implications of the Nuanced Clinical & Regulatory Considerations for Inflammasome Therapeutics Across Different Diseases

Time: 10:30 am
day: Day 2


  • This panel gathers industry leaders and seasoned regulatory experts to dive into the nuanced requirements of different disease types with regard to patient selection criteria in clinical trials, the nuances of trial design, considerations for study endpoints, treatment duration, dosing regimens, comparator arms and beyond
  • Engage in this interactive session, ask your pressing questions to experts